Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-11

Clinical Trial Update: A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effectiveness and safety of lacosamide for migraine prophylaxis; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vimpat (lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2009-09-11